genome-engineering of model organisms. However, CRISPR-mediated gene targeting reports in Drosophila are still restricted to a few genes, use variable experimental conditions and vary in efficiency, questioning the universal applicability of the method. Here, we developed an efficient, two-step strategy to flexibly engineer the fly genome by combining CRISPR with recombinasemediated cassette exchange (RMCE). In the first step, two sgRNAs, whose activity had been tested in cell culture, were co-injected together with a donor plasmid into transgenic Act5C-Cas9, Ligase4 mutant embryos and the homologous integration events were identified by eye fluorescence. In the second step, the eye marker was replaced with DNA sequences of choice using RMCE enabling flexible gene modification. We applied this strategy to engineer four different loci, including a gene on the fourth chromosome, at comparably high efficiencies, suggesting that any fly lab can engineer their favourite gene for a broad range of applications within about three months.
replace the inserted DNA by any DNA of choice using RMCE, an established standard technology in Drosophila 14 . Together, this allows flexible cassette exchange to freely manipulate the gene of interest. We successfully applied this method to four different loci and efficiently generated several allele variants, including a conditional allele, from a single targeting event. Our streamlined CRISPR/Cas9-and RMCEbased strategy makes it practical to flexibly engineer any Drosophila gene of choice for a broad range of applications within about three months.
Results

Strategy overview
We aimed to develop a versatile and efficient strategy to modify the Drosophila genome, which would allow various genome modifications such as the introduction of single point mutations, protein tags, exon deletions or other desired changes in the gene of choice. Despite the suggested higher efficiency of CRISPR/Cas9-induced HDR as compared to Zn-finger-or TALEN-induced HDR, the identification of successfully targeted carrier flies is still a limiting step in the process. PCR-based screening or melting curve analysis methods require DNA extraction 15 and thus are laborious and often inconvenient for efficient stock generation. Therefore, we decided to develop a 2-step strategy as illustrated in Figure 1 , which enables efficient identification of the carrier flies and allows entirely flexible genome engineering. In the first step, we insert a 3xP3-dsRed marker enabling easy identification of the HDR event. A strong splice acceptor, followed by STOP codons and an SV40 polyA terminator, precedes the dsRed cassette. The inserted DNA is flanked by two attP sites in opposite orientations, a strategy that we adapted from the popular MiMIC system 14 . If this cassette is inserted into an intron, or replaces an endogenous exon, it results in a truncated mRNA of the targeted gene. Thus, step 1 creates a loss of function allele (Figure 1 ).
In the second step, RMCE is applied to replace the DNA between both attP sites by any DNA of choice, leaving a minimal scar of two attR sites, preferably in introns. RMCE has been used very efficiently in the MiMIC system, demonstrating that attR sites in introns generally do not interfere with gene function 14 . Hence, our strategy enables the generation of various alleles, like a defined point mutation, a tagged allele, an exon replaced by a tag or a conditional allele, from a single HDR carrier ( Figure 1 ). This strategy should allow flexible editing of any Drosophila gene within about three months ( Figure 2 ).
CRISPR design and cloning
In step 1 we aimed to insert a STOP-3xP3-dsRed cassette flanked by two attP sites using a donor plasmid (Figure 1 ). Since the same strategy should be applicable to any gene, we established a single step Golden Gate protocol to assemble the STOP-dsRed donor plasmid containing about 1kb homology arms on each side, which has been shown to be of sufficient length for efficient HDR 16 and can be easily amplified by PCR. Cloning of the homology arms into the donor vector is thus very straightforward and takes only a few days for the gene of choice (Figure 3a , see Methods). This donor vector is the template for the HDR in step 1.
In step 2 RMCE exchanges the STOP-dsRed by any sequence located between 2 attB-sites in a provide plasmid ( Figure 1 ). RMCE works very reliably and a large collection of plasmids to tag genes or insert reporters for various applications is available 14 . These plasmids are fully compatible with our step 2 design. We have generated additional "generic" attB plasmids that can be used to tag any gene with a 2xTY1-V5 tag or to engineer a conditional allele using an FRT flanked 2xTY1 cassette followed by a V5 tag ( Figure 3b ). Flp mediated deletion of the 2xTY1 cassette will lead to a frame shift and can thus be used to create loss of function clones at very high efficiency, as the flip-out will occur in cis 17 . We have generated both constructs in all three reading frames.
CRISPR activity assay in cell cuture
Many search algorithms exist to predict sgRNA target sequences for a given gene region 18 . However, to date there is no simple way of confirming if any of the predicted sgRNAs work efficiently. We developed such a selection assay to be able to only inject effective sgRNAs into fly embryos. We designed 12 different sgRNAs targeting different regions in the salm gene and synthesized the sgRNAs by a standard PCR and in vitro transcription reaction ( Figure 3c ). These sgRNAs were then individually transfected into Cas9 expressing S2 cells 19 , and their cleavage efficiency was determined with a simple T7-Endonuclease I assay (see Methods). On average, about half of the tested sgRNAs work efficiently in this assay ( Figure 3d and data not shown), strongly suggesting that such a pre-selection test is useful to improve the in vivo success rates.
Step 1 -HDR in Lig4 mutant embryos
To test the efficiency of inserting our STOP-dsRed cassette, we designed three donor constructs targeting different regions in the salm gene ( Figure 4a ): the first, deleting parts of exon 1; the second, inserting the cassette into intron 1; and the third, deleting exon 3. For each construct about 1 kb homology arms were cloned in the STOP-dsRed donor vector. We injected the STOP-dsRed donor as circular plasmid together with 2 plasmids each containing a U6 promoter driven sgRNA verified in S2 cells and a hsp70-Cas9 source (see Methods). We injected into Ligase4 mutant embryos, which were reported to exhibit a higher rate of HDR than wild-type embryos 15, 16 . We injected between 700 and 1500 embryos for each of the three constructs and were able to recover 11 red eyed F1 carriers from 2 independent founders for the first intron construct and 72 red eyed F1s from 4 independent founders for the third exon deletion construct (Table 1 ). This demonstrated that our strategy works in principle, but as we failed to recover the first exon deletion allele, we wanted to further improve the efficiency by using a different Cas9 source.
Step 1 -transgenic Cas9 improves HDR efficiency
A number of transgenic Cas9 flies have been recently generated, some of which have been used successfully 6, 12, 13 . To test weather a transgenic Cas9 source is indeed more efficient for HDR than a source from an injected plasmid, we targeted the same loci as above, but now using Act5C-Cas9, Lig4 flies. For this, we recombined an Act5C-Cas9 transgene expressing Cas9 ubiquitously, including maternally in the germ-line, with the Lig4[169] null allele. Additionally, we removed the white and 3xP3dsRed markers from the Act5C-Cas9 transgene to obtain a Act5C-Cas9, Lig4 [169] chromosome that is useful for the injection of our donor plasmids (see Methods). We injected 700 Act5C-Cas9, Lig4[169] embryos with two in vitro transcribed sgRNAs targeting either the 1 st exon, the 1 st intron or the 3 rd exon of salm (using the same sgRNA target sequences as used above). We obtained 1, 9 and 4 independent founders producing 13, 54 and 59 F1 carriers, respectively, demonstrating that all 3 loci were targeted successfully with frequencies between 3 and 14 % per fertile G 0 (Table 1 ). To verify that the targeted insertion occurred correctly, we tested a total of 9 independent carriers from the 3 loci by PCR and sequencing and were able to confirm all of them.
The first step of our gene targeting strategy inserts a strong splice acceptor followed by a STOP cassette into the gene and thus should terminate transcription at this position. By design, the salm[1 st exon-dsRed] allele additionally has a deleted ATG. As expected, the salm[1 st exon-dsRed] allele is homozygous lethal, as well as lethal in trans to salm [1] , demonstrating that we indeed created a strong salm loss of function allele (Figure 5a ). The salm[1 st intron-dsRed] allele harbours an insertion in the first intron ( Figure 4a ). This allele is also homozygous lethal, and lethal in trans to salm [1] suggesting that the splice acceptor and STOP cassette are used efficiently to create a strong loss of function allele (Figure 5a ). The salm[3 rd exon-dsRed] allele only deletes the last 36 amino acids of the long SalmPA isoform, including 10 amino acids of the last zinc finger (Figure 4a ). This allele is homozygous viable, but flightless (Figure 5a ), implying a role for the last zinc finger in flight muscle function.
Taken together, these data suggest that our CRISPR-mediated step 1 strategy works efficiently to isolate targeted carrier flies at a practical frequency for routine use.
Conveniently, these step 1 alleles are loss function alleles if the insertion is located within the gene.
Step 2 -Flexible gene editing by RMCE
A major benefit of our editing strategy is the flexible step 2 that enables the nearseamless insertion of any DNA sequence with only two remaining attR sites ( Figure   1 ). To test the feasibility of step 2, we chose the salm[1 st intron-dsRed] allele. We exchanged the STOP-dsRed cassette with a short 2xTY1-V5 exon, a FRT-2xTY1-FRT-V5 conditional exon and a large GFP-3xFLAG exon from 14 (Figure 4b ). As expected, in all three cases the cassette exchange worked routinely (see Methods).
Importantly, the salm[1 st intron-dsRed] lethality was reverted by RMCE in all three cases ( Figure 5b ). This demonstrates that our editing protocol generally does not result in any unwanted harmful mutations on the edited chromosome.
Salm protein is expressed in indirect flight muscles (IFMs) and is essential for fibrillar IFM fate specification 20 . Thus, we should detect the tagged Salm protein versions in the IFM nuclei of adult flies. Indeed, tagged protein from all three alleles,
salm[1 st intron-TY1-V5], salm[1 st intron-FRT-TY1-FRT-V5] and salm[1 st intron-
GFP-FLAG] is expressed in IFMs. Salm-TY1-V5 and Salm-GFP-FLAG are readily detected in the IFM nuclei, Salm-FRT-TY1-FRT-V5 shows an additional dotty pattern in the cytosol (Figure 4c 
Gene editing on the fourth chromosome
In order to demonstrate the general applicability of our gene editing strategy, we decided to apply it to an additional locus. We chose the bent gene, located on chromosome four, which is highly heterochromatic and thus difficult to manipulate by standard genetic tools. To our knowledge, there is only a single case reported in the literature that targeted a gene located on the fourth chromosome by classical ends-out mediated homologous recombination using long homology arms 21 . bent encodes for a very large gene composed of at least 46 exons that are spread across more than 51 kb of genomic DNA ( Figure 5 ). bent encodes for Projectin, a titin-like protein, which is specifically expressed in muscles and essential for correct sarcomeric organisation [22] [23] [24] .
It is supposedly silent in germ cells in which the targeting event must happen. We chose to delete exon 11, an exon at the beginning of the PEVK domain of Projectin 25 , using two sgRNAs flanking the exon. Both sgRNAs tested positively in the S2 cell assay ( Figure 5 and data not shown). We again used approximately 1kb homology arms and injected the donor vector into 700 Act5C-Cas9, Lig4[169] embryos. We isolated 5 carriers from 1 founder out of a total of 56 fertile G 0 flies, an HDR efficiency of 1.8 %. We confirmed the bt[11 th intron-dsRed] allele by sequencing the locus. As expected, bt[11 th intron-dsRed] is homozygous lethal and also lethal in trans to bt[I-b], a strong bent allele 23 , again suggesting that the inserted splice acceptor is used effectively and transcription is prematurely terminated. Together, these results demonstrate that our CRISPR-mediated targeting strategy also works efficiently on the fourth chromosome, suggesting it can be generally applied to any locus of choice in the fly genome.
Discussion
CRISPR/Cas9 has been used successfully in many model organisms to generate mutants or to introduce targeted changes by HDR 1 . In Drosophila, there has been no general agreement regarding which strategy works most effectively to engineer the genome. To simply mutate a gene by CRISPR/Cas9-induced NHEJ, Cas9 was either injected as mRNA 7, 9 , provided from an injected plasmid 4, 11 or provided from a transgenic source 5, 6, 8 . Similarly, the sgRNA was either injected as in vitro transcribed sgRNA, or provided by an injected plasmid or a transgenic source. A standard protocol has not yet emerged although a number of genes have been mutated.
NHEJ can only induce small insertions or deletions. In contrast, HDR allows the defined engineering of a given gene and thus is suitable for a much wider range of applications. CRISPR/Cas9-mediated HDR has been used in Drosophila to insert short attP or tag sequences from single strand oligonucleotides as donors 4 or larger cassettes including a dsRed marker cassette from a plasmid donor 10-13 again using various ways of injected or transgenic sources of sgRNAs or Cas9. The injected genotype was variable, sometimes Lig4 mutants were used 10,12 , sometimes not 4, [11] [12] [13] .
Often the detection of the targeted event required laborious fly screening by PCR 10, 26 .
Here we aimed to develop a universal and efficient CRISPR-based strategy that enables flexible genome engineering, including the insertion of large tags into the coding region of a gene or the generation of conditional alleles. This strategy should be generally applicable to most Drosophila genes. Our results confirmed that about 1 kb homology arms are of sufficient length to insert a large marker cassette, as has been suggested before for other loci 10, 12, 13 . Thus, we could develop an efficient donor plasmid assembly protocol, which facilitates cloning of the donor vector for any gene within a few days. Additionally, our data support the value of a quick pre-testing strategy of predicted sgRNAs in S2 cells to eliminate inefficient sgRNAs, which would likely reduce targeting efficiency in vivo. Conveniently, the same in vitro transcribed RNAs can be used for both, S2 cell transfections and embryo injections.
Our results suggest that indeed a transgenic Cas9 source mediates HDR effectively in versions. This method is particularly valuable for genes that harbour complex transcriptional control and function in many tissues such as salm or for genes that are exceptionally large and exhibit complex alternative splicing patterns such as bent. The 2-step strategy allows structure-function analysis at the endogenous locus without interfering with the regulatory regions included in introns, which cannot be achieve by simply inserting a cDNA at the transcriptional start site. The functionality of our method was verified by the reversion of the lethality for the step 2 alleles in the first intron of salm. This furthermore demonstrates that both steps do not generate additional unintended changes on the chromosome. Therefore, we hope that our strategy will promote the wide application of CRISPR-mediated HDR in Drosophila, making it a routine tool used in every fly lab like EMS mutagenesis or P-element mediated transformation were in the last century.
Methods
Fly strains and genetics
All fly work, unless otherwise stated, was performed at 25 °C under standard conditions. The Lig4[169] null allele 27 2xTY1-V5 fragments were synthesized as gBlocks (IDT) and cloned into the attB plasmid for all three reading frames. CC6-U6-gRNA_hsp70-Cas9-sgRNA1, 3,4,7,9: the CC6-U6-gRNA_hsp70-Cas9 vector was cut with BbsI (NEB) and the annealed sgRNA targeting oligos were cloned into it. The vas-ΦC31(3xP3-EGFP.attB) plasmid was obtained from Johannes Bischof 30 . The attB site was removed by digestion with SpeI, followed by re-ligation.
All plasmids for embryo injections were purified with PureLink® HiPure Plasmid
Midiprep Kit (Life technologies). Oligos are listed in Supplementary Table 1 .
sgRNA synthesis
The sgRNA dsDNA template was produced using overlap PCR with a small amount of a common sgRNA scaffold primer, a shorter sgRNA amplification primer and a sgRNA gene specific primer that includes the T7 promoter (Figure 3c) 19 . All sgRNA primer sequences are listed in Supplementary Table 1 . The PCR product was cleaned by Qiagen MinElute kit (Qiagen). The sgRNAs were transcribed with T7-
MEGAshortscript™ Kit (Life Technologies) and purified with MEGAclear™
Transcription Clean-Up Kit (Life Technologies).
Embryo injection
Pre-blastoderm embryos of the appropriate genotype were de-chorionated and injected with a FemtoJet apparatus (Eppendorf) using self-pulled glass needles 
Immunolabelling of IFMs.
Hemi-thoraces of adult Drosophila were prepared and stained as described 31 . rabbit anti-Salm was used at 1:50 32 , mouse anti-Flag (Sigma), mouse anti-V5 (Abcam) and rhodamine phalloidin (Invitrogen) were all used at 1:500.
Nuclei were visualized by embedding in Vectashield plus DAPI (Vector Laboratories)
and images were acquired on a Zeiss LSM780 confocal and processed with FIJI and Photoshop.
Detailed Drosophila genome engineering protocol by CRISPR-RMCE
(Will be deposited at http://www.nature.com/protocolexchange/)
1.
CRISPR-sgRNA design and donor plasmid cloning ~ 10 days
1.1
Verify sequence of the targeting region in the fly strain used and in the S2 cells by sequencing to identify potential polymorphisms compared to the published sequence.
1.2
For designing the sgRNA targeting sites, choose one of the web tools 18 Most growing colonies will be correct. 
Fly step 1 -CRISPR-mediated HDR ~ 6 weeks
3.3
Generate stocks from an individual F1 carrier by crossing to balancer flies resulting in an isogenised stock for the engineered chromosome. Verify the correct orientation of the RMCE by PCR (will be ~50%). Overview of the 2-step procedure. In step 1, a donor vector consisting of two attP sites (P), a splice acceptor (SA), STOP codons (yellow box, black asterisk) followed by an SV40 polyadenylation signal (pA) and a 3xP3dsRed marker are inserted upon Cas9 cleavage with two sgRNAs. The orange coding exon is excised. In step 2, ΦC31-mediated RMCE inserts any DNA sequence between the 2 attB sites (B).
Figure legends
Examples for various engineered exons are given, resulting in attR sites (R) in introns. The entire genomic bent organisation is shown at the top with a 10 kb zoom-in below.
Coding exons are in orange. The sgRNA targeting sites flanking exon 11 are indicated by red arrows and the resulting bent allele is shown at the bottom. Step 1:
Step 2: 
